Medtronic Minimed: FDA filings under this applicant name
FDA lists 57 510(k) clearances under 3 spellings of the applicant name “Medtronic Minimed” (first 1986, latest 2026), plus 7 PMA decisions, across 15 product codes in 2 review panels. Median 510(k) review time under this name: 81 days. Since 2017 the median was 71 days, against 194 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Medtronic, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 1 | 66 |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 1 | 8 |
| 2016 | 1 | 177 |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 1 | 392 |
| 2023 | 0 | — |
| 2024 | 2 | 44 |
| 2025 | 2 | 110 |
| 2026 | 6 | 67 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Medtronic Minimed took a median 71 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 194 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| LZG | Pump, Infusion, Insulin | 15 | 15 |
| FRN | Pump, Infusion | 13 | 13 |
| FPA | Set, Administration, Intravascular | 12 | 12 |
| MDS | Sensor, Glucose, Invasive | 4 | 0 |
| QJI | Interoperable Automated Glycemic Controller | 4 | 4 |
| KZH | Introducer, Syringe Needle | 3 | 3 |
| QFG | Alternate Controller Enabled Insulin Infusion Pump | 3 | 3 |
| FPK | Tubing, Fluid Delivery | 2 | 2 |
| NDC | Calculator, Drug Dose | 2 | 2 |
| FRW | Scale, Patient | 1 | 1 |
Plus 5 more product codes.
Review panels
- Clinical Chemistry (32)
- General Hospital (32)
Most recent Medtronic Minimed 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K261962 | SmartGuard Technology; Predictive Low Glucose Technology | QJI | 2026-07-09 | 28 |
| K253743 | MiniMed Flex pump | QFG | 2026-03-12 | 108 |
| K253701 | SmartGuard Technology; Predictive Low Glucose Technology | QJI | 2026-02-03 | 71 |
| K253470 | MiniMed 780G Insulin Pump (MMT-1884); MiniMed 780G Insulin Pump Kit (MMT-1894) | QFG | 2026-01-15 | 97 |
| K253585 | SmartGuard technology; Predictive Low Glucose technology | QJI | 2026-01-14 | 58 |
| K253512 | MiniMed Go App | NDC | 2026-01-08 | 63 |
| K251217 | SmartGuard technology; Predictive Low Glucose technology | QJI | 2025-08-29 | 130 |
| K251032 | MiniMed 780G insulin pump | QFG | 2025-07-01 | 89 |
| K242775 | InPen System App (MMT-8060 (iOS), MMT-8061 (Android)) | NDC | 2024-11-12 | 60 |
| K241622 | Extended Reservoir; MiniMed Reservoir | LZG | 2024-07-02 | 27 |
47 earlier clearances. See the full list in Caduvo.
PMA and De Novo decisions
| Number | Pathway | Device | Decision date |
|---|---|---|---|
| P250012 | PMA | Simplera Sync Sensor, Guardian 4 Sensor | 2025-08-06 |
| P160007 | PMA | Guardian Connect system | 2018-03-08 |
| P160017 | PMA | MiniMed 670G System | 2016-09-28 |
| P150001 | PMA | MINIMED 630G SYSTEM WITH SMARTGUARD(TM) | 2016-08-10 |
| P150029 | PMA | IPRO2 CGM SYSTEM WITH ENLITE SENSOR | 2016-06-17 |
Recalls
99 product recalls in 45 recall events; 57 initiated in the last five years. Most recent: 2026-09-11.
15 product recalls in 9 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 0 initiated in the last five years. Most often: Medtronic Inc. (15).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Device clinical trials
An industry sponsor named Medtronic Minimed is the lead sponsor of 69 device studies on ClinicalTrials.gov (5 active or recruiting). Most recent:
- NCT07401901: Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes (Not yet recruiting, started 2026-10-15)
- NCT07864168: Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes (Recruiting, started 2026-10-05)
- NCT07227805: Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS) (Recruiting, started 2026-07-19)
- NCT07675161: MiniMed Fit Payload Wear Pediatric Study (Completed, started 2026-06-25)
- NCT07408141: MiniMed Fit Payload Wear Study (Completed, started 2026-02-19)
Parent company SEC filings
Medtronic plc (MDT): EDGAR filings, CIK 1613103. Caduvo groups Medtronic Minimed under Medtronic; the parent's SEC registrant is entered by hand for the group, not matched by name.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Medtronic Minimed (a text match, not an official crosswalk):
- A4220 — Refill kit for implantable infusion pump (via MRZ)
- E0786 — Implantable programmable infusion pump, replacement (excludes implantable intraspinal catheter) (via MRZ)
- E0785 — Implantable intraspinal (epidural/intrathecal) catheter used with implantable infusion pump, replacement (via FRN)
FDA spellings included
FDA records this applicant under 3 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Medtronic Minimed (53)
- Medtronic Minimed, Inc. (10)
- Medtronic MiniMed (1)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Medtronic Vascular (480 510(k)s)
- Medtronic Sofamor Danek (253 510(k)s)
- Medtronic, Inc. (249 510(k)s)
- Medtronic Sofamor Danek USA, Inc. (185 510(k)s)
- Medtronic Xomed, Inc. (47 510(k)s)
- Medtronic Navigation, Inc. (45 510(k)s)
- Medtronic Perfusion Systems (29 510(k)s)
- Medtronic Neurosurgery (27 510(k)s)
- Medtronic Blood Systems, Inc. (15 510(k)s)
- Medtronic PS Medical (14 510(k)s)
- Medtronic Ave, Inc. (13 510(k)s)
- Medtronic Bio-Medicus, Inc. (13 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Medtronic Minimed?
FDA lists 57 510(k) clearances under 3 spellings of the applicant name “Medtronic Minimed” (first 1986, latest 2026), plus 7 PMA decisions, across 15 product codes in 2 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Medtronic Minimed?
The median time from FDA receipt to decision across 510(k)s cleared under the name Medtronic Minimed is 81 days. Since 2017: 71 days, versus 194 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Medtronic Minimed?
The most frequent FDA product codes under this applicant name are LZG (Pump, Infusion, Insulin, 15); FRN (Pump, Infusion, 13); FPA (Set, Administration, Intravascular, 12).
Next steps
- See all 57 Medtronic Minimed clearances with predicates and recalls
- Run predicate analysis for product code LZG, Medtronic Minimed's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.